Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin

American Journal of Pathology

Volumn 163, Issue 3, 2003, Pages 879-887

  Sarlos, Stella ^a   Rizkalla, Bishoy ^b   Moravski, Christina J ^a   Cao, Zemin ^b   Cooper, Mark E ^b   Wilkinson Berka, Jennifer L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOPOIETIN; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR; OXYGEN; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; NERVE CELL; NEWBORN; NONHUMAN; OSMOTIC MINIPUMP; OXYGEN THERAPY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; RETINA; RETROLENTAL FIBROPLASIA;

EID: 0041924832     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63448-7     Document Type: Article

References (58)

1. Klein R, Klein B, Moss S: Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992, 15:1875-1891
2. Fryczkowski A, Hodes B, Walker J: Diabetic choroidal and iris vasculature scanning electron microscopy findings. Int Ophthalmol Clin 1989, 13:269-279
3. Phelps DL: Retinopathy of prematurity. Pediatr Rev 1995, 16:50-56
4. Schalekamp MADH: Renin-angiotensin system components and endothelial proteins as markers of diabetic microvascular disease. Clin Invest 1993, 71:S3-S6
5. Danser AHJ, Van den Dorpel MA, Deinum J, Derkx FHM, Franken AAM, Peperkamp E, de Jong PTVM, Schalekamp MADH: Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy. J Clin Endocrinol Metab 1989, 68:160-167
6. Chaturvedi M, Sjolie AK, Stephenson JM, Abrahamian H, Keipes M: Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. Lancet 1998, 351:28-31
7. Moravski CJ, Kelly DJ, Cooper ME, Gilbert RE, Bertram J, Shahinfar S, Skinner SL, Wilkinson-Berka JL: Retinal neovascularization is prevented by blockade of the renin-angiotensin system. Hypertens 2000, 36:1099-1104
8. Le Noble FA, Schreurs NH, van Straaten HW, Slaaf D, Smits JF, Rogg H. Struijker-Boudier HA: Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am J Physiol 1993. 264:460-465
9. Tamarat R, Silvestre JS, Durie M, Levy BI: Angiotensin II angiogenic effect in vivo involves vascular endothelial growth factor- and inflammation-related pathways. Lab Invest 2002, 82:747-756
10. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ: Multiple autocrine growth factors modulate vascular smooth muscle cell growth in response to angiotensin II. J Clin Invest 1993, 91:2268-2274
11. Otani A, Takagi H, Suzuma K, Honda Y: Angiotensin II potentiates endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 1998, 82:619-628
12. Nadal JA, Scicli GM, Carbini LA, Scicli AG: Angiotensin II stimulates migration of retinal microvascular pericytes: involvement of TGF-β and PDGF-BB. Am J Physiol 2002, 282:H739-H748
13. Perio C, Rodriguezlopez AM, Angulo J, Regadera J, Marin J, Sanchezferrer CF, Lopeznovoa JM: Endogenous angiotensin II and cell hypertrophy in vascular smooth muscle cultures from hypertensive Ren-2 transgenic rats. Cell Physiol Biochem 1998, 8:106-116
14. 2 receptors Kidney Int 1998, 54: S95-S99
15. Tebbs C, Pratten MK, Broughton Pipkin F: Angiotensin II is a growth factor in the peri-implantation rat embryo. J Anat 1999, 195:75-86
16. Cao Z, Kelly DJ, Cox A, Casley D, Forbes JM, Martinello P, Dean R, Gilbert RE, Cooper ME: Angiotensin type 2 receptor is expressed in the adult rat kidney and promotes cellular proliferation and apoptosis. Kidney Int 2000, 58:2437-2451
17. Levy BI, Benessiano J, Henrion D, Caputo L, Heymes C, Duriez M, Poitevin P, Samuel JL: Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996, 98:418-425
18. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ: The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer Proc Natl Acad Sci USA 1995, 92:10663-10667
19. Munzenmaier DH, Greene AS: Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertens 1996, 27:760-765
20. Akishita M, Ito M, Lehtonen JYA, Daviet L, Dzau VJ, Horiuchi M: Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth. J Clin Invest 1999, 103:63-71
21. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE: Expression of AT2 receptors in the developing rat fetus. J Clin Invest 1991, 88:921-933
22. Ferrara N: Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am J Physiol 2001, 280: C1358-1366
23. De Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992, 255:989-991
24. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W, Ullrich A: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72:835-846
25. Gilbert R, Vranes D, Berka JL, Cox A, Kelly DJ, Stacker S, Cooper ME: Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. Lab Invest 1998, 78:1017-1027
26. Sato TN, Tozawa Y, Deutsch U, Wolburgbuchholz K, Fujiwara Y, Gendronmaguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation Nature 1995, 376:70-74
27. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand S, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60
28. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996, 87:1161-1169
29. Asahara T, Chen D, Takahashi T, Fujikawa K, Kearney M, Magner M, Yancopoulos GD, Isner JM: Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization. Circ Res 1998, 83:233-240
30. Otani A, Takagi H, Oh H, Koyama S, Honda Y: Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells. Diabetes 2001, 50:867-875
31. Fujiyama S, Matsubara H, Nozawa Y, Maruyama K, Mori Y, Tsutsumi Y, Masaki H, Uchiyama Y, Koyama Y, Nose A, Iba O, Tateishi E, Ogata N, Jyo N, Higashiyama S, Iwasaka T: Angiotensin AT1 and AT2 receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 2001, 88:22-29
32. Cao Z, Dean R, Wu L, Casley D, Cooper ME: Role of angiotensin receptor subtypes in mesenteric vascular proliferation and hypertrophy. Hypertens 1999, 34:408-414
33. Cao Z, Bonnet F, Candido R, Nesteroff SP, Burns WC, Kawaci H, Shimizu F, Carey RM, de Gasparo M, Cooper ME: Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J Am Soc Nephrol 2002, 13:1773-1787
34. Hu DE, Hiley CR, Fan TP: Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3, and angiotensin II in a rat sponge model. Br J Pharmacol 1996, 117:545-551
35. LeNoble FAC, Hekking JWM, Van Straaten HWM, Slaaf DW, Struykey Boudier HAJ: Angiotensin II stimulates angiogenesis in the chorioallantoic membrane of the chick embryo. Eur J Pharmacol 1991, 195:305-306
36. Scheidegger KJ, Wood JM: Local application of angiotensin II to the rat carotid artery induces adventitial thickening. J Vasc Res 1997, 34:436-446
37. Fernandez L, Twickler J, Mead A: Neovascularization produced by angiotensin II. J Lab Clin Med 1985, 105:141-145
38. Emanueli C, Salis MB, Stacca T, Pinna A, Gaspa L, Maddeddu P: Angiotensin AT(1) receptor signalling modulates reparative angiogenesis induced by limb ischaemia. Br J Pharmacol 2002, 135;87-92
39. 2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler Thromb Vasc Biol 1997, 17:257-264
40. Lonchampt M, Pennel L, Duhault J: Hyperoxia/normoxia-driven retinal angiogenesis in mice: a role for angiotensin II. Invest Ophthalmol Vis Sci 2001, 42:429-432
41. Kunert-Radek J, Stepien H, Komorowski J, Pawlikowski M: Stimulatory effect of angiotensin II on the proliferation of mouse spleen lymphocytes in vitro is mediated via both types of angiotensin II receptors. Biochem Biophys Res Commun 1994, 198:1034-1039
42. 2 receptors. Kidney Int 2002, 61:1886-1995
43. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T: The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells J Clin Invest 1995, 95:651-657
44. Wheeler-Schilling TH, Kohler K, Sautter M, Guenther E: Angiotensin II receptor subtype gene expression and cellular localization in the retina and non-neuronal ocular tissues of the rat. Eur J Neurosci 1999, 11:3387-3394
45. Murata M, Nakagawa M, Takahashi S: Expression and localization of angiotensin II type 1 receptor mRNA in rat ocular tissues. Ophthalmologica 1997, 211:384-386
46. Daud AI, Bumpus FM, Husain A: Angiotensin II: does it have a direct obligatte role in ovulation? Science 1989, 245:870-871
47. Nork T, Wallow I, Sramek S, Anderson G: Muller cells involvement in proliferative diabetic retinopathy. Arch Ophthalmol 1987, 105:1424-1429
48. Stone J, Itin A, Alon T, Peer J, Gnessin H, Chan-Ling T, Keshet E: Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 1995, 15:4738-4747
49. Gruden G, Thomas S, Burt D, Zhou W, Chusney G, Gnudi L, Viberti G: Interaction of angiotensin II and mechanical stretch on vascular endothelial growth factor production by human mesangial cells. J Am Soc Nephrol 1999, 10:730-737
50. Sasaki K, Murohara T, Ikeda H, Sugaya T, Shimada T, Shintani S, Imaizumi T: Evidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis. J Clin Invest 2002, 109:603-611
51. Amaral S, Roman R, Greene A: Renin gene transfer restores angiogenesis and vascular endothelial growth factor expression in Dahl's rats. Hypertens 2001, 37:386-390
52. Yoshiji H, Kuriyama S, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Nakatani T, Tsujinoue H, Fukui H: The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res 2001, 7:1073-1078
53. Lobov IB, Brooks PC, Lang RA: Angiopoietin-2 displays VEGF-dependent modulation of capillary structure and endothelial cell survival in vivo. Proc Natl Acad Sci USA 2002, 99:11205-1210
54. Hackett SF, Ozaki H, Strauss RW, Wahlin K, Suri C, Maisonpierre P, Yancopoulos G, Campochiaro PA: Angiopoietin 2 expression in the retina: up-regulation during physiologic and pathologic neovascularization. J Cell Physiol 2000, 184:275-284
55. Hangai M, Moon YS, Kitaya N, Chan CK, Wu DY, Peters KG, Ryan SJ, Hinton DR: Systemically expressed soluble Tie2 inhibits intraocular neovascularization. Hum Gene Ther 2001, 12:1311-1321
56. Enholm B, Paavonen K, Ristimaki A, Kumar V, Gunji Y, Klefstrom J, Kivinen L, Laiho M, Olofsson B, Joukov V, Eriksson U, Alitalo K: Comparison of VEGF, VEGF-B, VEGF-C, and Ang-1 mRNA regulation by serum, growth factors, oncoproteins, and hypoxia. Oncogene 1997, 14:2475-2483
57. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y: Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999, 274:15732-15739
58. Joussen AM, Poulaki V, Tsujikawa A, Qin W, Qaum T, Xu Q, Moromizato Y, Bursell SE, Wiegand SJ, Rudge J, loffe E, Yancopoulos GD, Adamis AP: Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol 2002, 160:1683-1693